Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorErasmus Medical Center
About this trial
The goal of this single center prospective observational study is to determine the effect of chemotherapy on (the change in) vital parameters. The main question it aims to answer are: Can changes in vital parameters be measured by using a Fitbit in patients with cancer while undergoing chemotherapy. Participants will be asked to wear a Fitbit for the first two cycles of chemotherapy to evaluate the changes in vital parameters.
Eligibility criteria
Qualifiers
Age ≥18 years;
Diagnosis of stomach or esophageal cancer with an indication of starting chemotherapy
Knowledge how to handle a Fitbit
Mastery of Dutch language
Disqualifiers
Cognitive disorders or severe emotional instability
Already participating in an exercise trial
Trial design
Treatments tested in this trial
- Proactive Monitoring
Treatment groups
175 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov